Market Share

A small-town medical spa is investing in cutting-edge tech for body, bladder, and brain. Is this the future of healthcare or a high-stakes gamble?

New clinical trial results for XWRAP® show a significant leap in healing diabetic ulcers, positioning Applied Biologics as a formidable player in a challenging field.

Jeep revives the Trailhawk and Overland, but the real story is a calculated move by Stellantis to reinforce its core brand identity in a shifting market.

Netflix's expanded iHeartMedia deal isn't just about more shows; it's a calculated move to conquer daytime viewing and redefine streaming engagement.

A new data-driven framework aims to move senior living beyond bingo attendance, tackling the silent epidemic of loneliness. But can technology truly measure connection?

Lexeo Therapeutics finalizes a pivotal trial for its Friedreich ataxia gene therapy, leveraging a novel trial design and accelerated FDA pathway.

New research reveals why employees bypass corporate travel tools: they can't find what they need. This 'invisible spend' is costing firms millions.

Stunning new US/EU data for BTK inhibitor orelabrutinib signals a major push into Western markets, challenging established blood cancer therapies.

SINTRONES unveils rugged Edge AI at EUROSATORY 2026, processing data on the front lines. This move toward decentralized intelligence and data sovereignty redefines resilience.

While Nevada's cannabis market contracts, C21 Investments posts record customer growth and an 8% revenue jump, fueled by a high-stakes tax challenge.

As the utility-scale solar industry grapples with labor shortages and tight deadlines, one Texas firm is sharpening its message: execution is everything.

MBX Biosciences' new one-year data for canvuparatide isn't just a clinical win; it's a calculated move to dominate a billion-dollar market left vacant.

While firms spend billions on tech, a new book argues the biggest data breaches stem from leadership gaps and process failures. Is your boardroom the real front line?

Beyond solar panels and ESG reports, JFK's $9.5B New Terminal One is a blueprint for climate-proof infrastructure. Here’s why it redefines the 2026 travel experience.

Abridge unveils a sweeping AI platform to combat clinician burnout and mend a fragmented system by linking care delivery, payment, and research.

Explore how TESCO Metering's latest innovation, the Universal SIM, and its expanded Adaptiv Ecosystem are set to dismantle vendor lock-in for a new era of grid modernization.

ŌURA's blockbuster deals with football icons Harry Kane and Declan Rice are more than just endorsements; they are a calculated move in the high-stakes wearables war.

A new heavy-lift drone can autonomously airdrop supplies into contested zones with precision, signaling a fundamental shift in military and humanitarian aid.

Bee You Organics' recent award is more than a win for a small brand. It's a signal that the CPG landscape is being reshaped by waterless innovation.

WyreStorm unveils its Synergy Control Flow, betting on open-source logic and AI to slash AV integration time. Can this challenge the proprietary giants?